Drug Approval | July 14, 2022
Shilpa Medicare’s Unit VI, Bengaluru facility has been issued UK MHRA GMP
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Govt committed to supporting pharma companies with industry-friendly policies
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Subscribe To Our Newsletter & Stay Updated
